Insider Selling: CME Group Inc (CME) Chairman Sells 20,000 Shares of Stock

CME Group Inc (NASDAQ:CME) Chairman Terrence A. Duffy sold 20,000 shares of the firm’s stock in a transaction on Tuesday, February 6th. The shares were sold at an average price of $151.66, for a total value of $3,033,200.00. Following the completion of the transaction, the chairman now owns 99,239 shares of the company’s stock, valued at approximately $15,050,586.74. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Shares of CME Group Inc (CME) opened at $156.85 on Friday. The company has a market capitalization of $53,370.00, a PE ratio of 13.14, a P/E/G ratio of 2.09 and a beta of 0.64. CME Group Inc has a 52-week low of $114.82 and a 52-week high of $163.00. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.05 and a current ratio of 1.03.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.12 EPS for the quarter, topping analysts’ consensus estimates of $1.10 by $0.02. The firm had revenue of $900.00 million during the quarter, compared to analysts’ expectations of $886.85 million. CME Group had a return on equity of 7.68% and a net margin of 111.49%. The firm’s quarterly revenue was down 1.4% compared to the same quarter last year. During the same quarter last year, the business posted $1.14 EPS. analysts expect that CME Group Inc will post 6.26 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 26th. Investors of record on Friday, March 9th will be given a dividend of $0.70 per share. This represents a $2.80 dividend on an annualized basis and a yield of 1.79%. The ex-dividend date is Thursday, March 8th. This is a boost from CME Group’s previous quarterly dividend of $0.66. CME Group’s dividend payout ratio (DPR) is currently 22.11%.

A number of research analysts have recently weighed in on CME shares. Royal Bank of Canada raised their price target on CME Group from $135.00 to $147.00 and gave the company an “outperform” rating in a research report on Monday, October 16th. BidaskClub cut CME Group from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, October 18th. Citigroup raised their price target on CME Group from $138.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, October 19th. Zacks Investment Research upgraded CME Group from a “hold” rating to a “buy” rating and set a $164.00 price target for the company in a research report on Tuesday, January 2nd. Finally, Berenberg Bank started coverage on CME Group in a research report on Thursday, January 25th. They issued a “hold” rating and a $170.00 price target for the company. Three investment analysts have rated the stock with a hold rating, eleven have given a buy rating and one has issued a strong buy rating to the company’s stock. CME Group has an average rating of “Buy” and a consensus price target of $157.00.

Institutional investors have recently bought and sold shares of the stock. Quadrant Capital Group LLC increased its position in CME Group by 13.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 944 shares of the financial services provider’s stock worth $111,000 after purchasing an additional 113 shares in the last quarter. Valeo Financial Advisors LLC purchased a new stake in CME Group in the 3rd quarter valued at about $124,000. Bank of Nova Scotia Trust Co. purchased a new stake in CME Group in the 3rd quarter valued at about $165,000. SeaCrest Wealth Management LLC purchased a new stake in CME Group in the 4th quarter valued at about $203,000. Finally, LaFleur & Godfrey LLC purchased a new stake in CME Group in the 3rd quarter valued at about $204,000. Hedge funds and other institutional investors own 82.65% of the company’s stock.

WARNING: This report was reported by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this report on another domain, it was illegally copied and reposted in violation of US & international trademark & copyright legislation. The legal version of this report can be accessed at

About CME Group

CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply